| Zimbabwe | | |
New HIV infections (per 1000 uninfected population) | 1.74 (2020) [9/130countries] | | | Tuberculosis incidence (per 100,000 population) | 190.0 (2021) [41/198countries] | | | Hepatitis B surface antigen (HBsAg) prevalence among children under 5 years (%) | 2.7 (2020) [18/194countries] | | | Probability of dying from any of CVD, cancer, diabetes, CRD between age 30-70 (%) | 28.4 (2019) [18/183countries] | | |
|
| Zimbabwe | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 200.4 (2020) [67/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 2.7 (2020) [110/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 2.2 (2020) [108/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 39.2 (2020) [117/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 61.7 (2020) [5/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 4.4 (2020) [139/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 6.9 (2020) [97/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.6 (2020) [100/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.2 (2020) [146/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.5 (2020) [93/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 2.2 (2020) [156/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.4 (2020) [132/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 9.0 (2020) [37/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 5.3 (2020) [137/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 8.0 (2020) [64/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 3.2 (2020) [29/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.6 (2020) [58/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 10.1 (2020) [36/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 11.3 (2020) [7/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [120/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 6.0 (2020) [100/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 2.4 (2020) [125/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 70.6 (2020) [35/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 9.4 (2020) [47/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.2 (2020) [155/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 1.9 (2020) [132/184countries] | | |
|
| Zimbabwe | | |
Suicide, age-standardized (per 100 000 population) | 23.63 (2019) [7/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 37.81 (2019) [11/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 13.46 (2019) [3/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 11.46 (2019) [36/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 16.88 (2019) [35/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 6.22 (2019) [34/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 13.50 (2019) [38/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 20.87 (2019) [37/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 7.61 (2019) [22/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 26.88 (2019) [15/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 34.58 (2019) [22/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 20.44 (2019) [3/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 48.36 (2019) [5/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 74.97 (2019) [6/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 25.68 (2019) [2/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 51.49 (2019) [4/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 88.36 (2019) [5/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 24.31 (2019) [3/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 63.08 (2019) [3/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 113.30 (2019) [4/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 32.34 (2019) [2/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 88.29 (2019) [3/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 160.50 (2019) [3/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 53.36 (2019) [1/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 183.90 (2019) [12/183countries] | | |
|
|